The 2020 Innovation to Commercialization and Health Professional-Investigator awardees are applying research and innovations to improve health outcomes for British Columbians.
News Award Type: Innovation to Commercialization Program
MSFHR’s 2021 Suite of Funding Opportunities Will Enable Innovative Health Research Across BC
By investing in and supporting health research, we are continuing to support British Columbians through the pandemic and our province’s economic recovery.
Shining a (near-infrared) light on spinal cord injury treatment
Dr. Brian Kwon and his research team are using MSFHR funding to advance a novel technology to improve outcomes for patients with spinal cord injury.
Continue reading “Shining a (near-infrared) light on spinal cord injury treatment”
MSFHR and Mitacs partnership unlocks additional funding for applicants
MSFHR and Mitacs have partnered to support joint applications so researchers can access both Mitacs and MSFHR funding with one application. MSFHR and Mitacs have partnered to support joint applications so researchers can access both Mitacs and MSFHR funding with one application.
Continue reading “MSFHR and Mitacs partnership unlocks additional funding for applicants”
2020 Innovation to Commercialization competition now open. New for 2020: additional resources to support female innovators
Our 2020 Innovation to Commercialization (I2C) competition is now open. Read on for more details, including program competition changes for 2020.
MSFHR funds nine BC health researchers moving innovations towards practical application
Nine BC health researchers have been funded in MSFHR’s third Innovation to Commercialization (I2C) competition. Each will receive funding to advance their medical treatments, diagnostic tools and assistive technologies towards practical application to improve health outcomes and enrich the health innovation ecosystem in BC.
Calling health innovators: 2019 I2C competition open
Applications are now open for the 2019 Innovation to Commercialization competition. The letter of intent deadline is March 14, with full applications due May 2, 2019.
Continue reading “Calling health innovators: 2019 I2C competition open”
MSFHR-funded research identifies enzyme potentially responsible for skin blistering
2003 Scholar and 2017 I2C award recipient Dr. David Granville has identified an enzyme potentially responsible for skin blistering, and is developing an inhibitor to prevent and treat the condition.
MSFHR funds eight BC health researchers moving innovations towards practical application
Eight BC health researchers have been funded in MSFHR’s second Innovation to Commercialization competition, designed to help researchers advance discoveries or inventions towards practical application.
MSFHR-funded researcher discovers a new drug that could stop prostate cancer in its tracks
Christopher Ong, one of MSFHR’s first Innovation to Commercialization cohort, says his 2017 I2C award came at an opportune time in the development of a new drug that could stop prostate cancer in its tracks.